Mastodon

Solosorb (Gel) Instructions for Use

Marketing Authorization Holder

Grotex, LLC (Russia)

ATC Code

A07B (Intestinal adsorbents)

Active Substance

Polymethylsiloxane polyhydrate (Grouping name)

Dosage Form

Bottle OTC Icon Solosorb Gel for oral suspension: tubes 225 g

Dosage Form, Packaging, and Composition

Gel for the preparation of an oral suspension in the form of a moist mass of white or almost white color, consisting of jelly-like lumps of various sizes, odorless.

1 tube
Polymethylsiloxane polyhydrate 225 g

225 g – tubes – cardboard packs.

Clinical-Pharmacological Group

Enterosorbent

Pharmacotherapeutic Group

Enterosorbent agent

Pharmacological Action

Enterosorbing agent.

Polymethylsiloxane has a porous structure of an organosilicon matrix (molecular sponge) of a hydrophobic nature, which is characterized by a sorption action only towards medium-molecular-weight toxic metabolites (molecular weight from 70 to 1000).

Polymethylsiloxane has pronounced sorption and detoxification properties. In the lumen of the gastrointestinal tract, it binds and removes from the body endogenous and exogenous toxic substances of various natures, including bacteria and bacterial toxins, antigens, food allergens, medicinal products and poisons, salts of heavy metals, radionuclides, alcohol; it also sorbs some products of the body’s metabolism, including excess bilirubin, urea, cholesterol and lipid complexes, as well as metabolites responsible for the development of endogenous toxicosis.

Polymethylsiloxane does not reduce the absorption of vitamins and microelements, contributes to the restoration of disturbed intestinal microflora and does not affect its motor function.

Pharmacokinetics

Not absorbed in the gastrointestinal tract, excreted unchanged within 12 hours.

Indications

In adults and children as a detoxification agent: acute and chronic intoxications of various origins; acute poisonings with potent and poisonous substances, including medicinal products and alcohol, alkaloids, salts of heavy metals; acute intestinal infections of any genesis as part of complex therapy (foodborne toxic infections, salmonellosis, dysentery, diarrheal syndrome of non-infectious origin, dysbiosis); purulent-septic diseases accompanied by severe intoxication, as part of complex therapy; food and drug allergy; hyperbilirubinemia (viral hepatitis) and hyperazotemia (chronic renal failure); for the prevention of chronic intoxications in workers of hazardous industries (occupational intoxications with chemical agents of polytropic action, xenobiotics, incorporated radionuclides, lead, mercury, arsenic compounds, petroleum products, organic solvents, nitrogen oxides, carbon, fluorides, salts of heavy metals).

ICD codes

ICD-10 code Indication
A02 Other salmonella infections
A03 Shigellosis
A04 Other bacterial intestinal infections
A05 Other bacterial food poisonings, not elsewhere classified
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin (infectious diarrhea NOS)
A40 Streptococcal sepsis
A41 Other sepsis
B15 Acute hepatitis A
B16 Acute hepatitis B
B17 Other acute viral hepatitis
B18 Chronic viral hepatitis
E80.6 Other disorders of bilirubin metabolism
F10.0 Mental and behavioral disorders due to alcohol use – acute intoxication
F11.0 Mental and behavioral disorders due to opioid use – acute intoxication
F13.0 Mental and behavioral disorders due to use of sedatives and hypnotics – acute intoxication
K59.1 Functional diarrhea
K63.8 Other specified diseases of intestine
N18 Chronic kidney disease
R54 Acute intoxication
R79.8 Other specified abnormal findings of blood chemistry
T50.9 Other and unspecified drugs, medicaments and biological substances
T51 Toxic effect of alcohol
T52 Toxic effect of organic solvents
T56 Toxic effect of metals
T57 Toxic effect of other inorganic substances
T58 Toxic effect of carbon monoxide
T59 Toxic effect of other gases, fumes, and vapors
T65 Toxic effect of other and unspecified substances
T78.1 Other adverse food reactions, not elsewhere classified
T88.7 Unspecified adverse effect of drug or medicament
Z57 Occupational exposure to risk factors
ICD-11 code Indication
1A01 Intestinal infection caused by other Vibrio species
1A02 Intestinal infections due to Shigella
1A03.Z Intestinal infections caused by Escherichia coli, unspecified
1A09.Z Salmonella infection, unspecified
1A0Z Bacterial intestinal infections, unspecified
1A1Z Bacterial foodborne intoxications, unspecified
1A40.Z Infectious gastroenteritis or colitis, unspecified
1E50.0 Acute hepatitis A
1E50.1 Acute hepatitis B
1E50.Z Acute viral hepatitis, unspecified
1E51.Z Chronic viral hepatitis, unspecified
1G40 Sepsis without septic shock
4A85.21 Urticaria or angioedema caused by food
4A85.2Z Food hypersensitivity, unspecified
5C58.02 Dubin-Johnson syndrome
5C58.0Y Other specified disorders of bilirubin metabolism or excretion
5C90.1 Liver diseases due to disorders of porphyrin or bilirubin metabolism or transport
6C40.3 Alcohol intoxication (inebriation)
6C43.3 Opioid intoxication
6C44.3 Intoxication due to sedatives, hypnotics or anxiolytics
DA92.1 Pneumatosis intestinalis of the small intestine
DA98.Z Polyps of small intestine, unspecified
DB31.1 Pneumatosis of the colon
DB36.Z Certain infections of the colon, unspecified
DD91.2 Functional diarrhea
DD93.Y Other specified functional gastrointestinal disorders in infants, toddlers and school-age children
DD9Z Functional gastrointestinal disorders, unspecified
DE2Z Diseases of the digestive system, unspecified
GB61.Z Chronic kidney disease, unspecified stage
MA18.Z Abnormalities of blood chemistry, unspecified
MG2A Frailty syndrome
NE60 Poisoning by drugs, medicaments or biological substances, not elsewhere classified
NE61 Toxic effect of poisonous substances, chiefly nonmedicinal, not elsewhere classified
NE6Z Harmful effect of unspecified substance
NF09 Adverse effects, not elsewhere classified
QD84.Z Exposure to occupational risk factors, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer orally, maintaining an interval of 1-2 hours before or after meals or intake of any other medicinal products.

For adults, the dose is 15 g to 22.5 g (approximately one to one and a half tablespoons), taken three times daily.

For children aged 3 to 5 years, the dose is 7.5 g (approximately half a tablespoon), taken three times daily.

For children aged 1 to 3 years, the dose is 5 g (approximately one teaspoon), taken three times daily.

For infants up to 1 year, administer 2.5 g (approximately half a teaspoon). Mix the gel thoroughly with a triple volume of breast milk, infant formula, or water. Give this mixture before each feeding (typically six times daily).

In cases of severe intoxication, the dosage for adults may be doubled during the first three days of therapy, under medical supervision.

The average duration of treatment is 3 to 5 days for acute conditions. For chronic intoxications and allergic diseases, the course can be extended to 2-3 weeks, as directed by a physician.

For prophylactic use in occupational hazards, take the standard adult dose once or twice daily.

Adverse Reactions

From the digestive system nausea, constipation.

Contraindications

Intestinal atony.

Use in Pregnancy and Lactation

Not contraindicated during pregnancy and breastfeeding.

Pediatric Use

The drug is approved for use in children and adolescents under 18 years of age.

Special Precautions

Can be used in complex therapy with other medicinal products, provided the rule of separate administration in time is observed: 1-2 hours before or after taking other medicinal products.

Drug Interactions

When taken simultaneously, a decrease in the absorption of other medicinal products is possible.

Storage Conditions

Store at 2°C (36°F) to 30°C (86°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS